Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

CVS Health (CVS) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareHealthcare PlansCVS

Closing price · Nov 19, 2026 $80.02 -1.6% on the day · +7.0% over 12 months 52-week range $69.04 – $109.92
Get CVS alerts
Open-market purchases1 insider$2.0M · last 12 months
Insiders selling2last 12 months
Reported sales$324M0 of 8 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($2.0M), but sales were much larger ($324M) over the same 12 months.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Purchase Prem S. Shah, President bought 23,855 shares at $83.89 ($2.0M).

Trade date
Nov 6, 2026
Disclosed to the SEC
Nov 6, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All CVS insider trades ↓

✦ Read the full investigation of Prem S. Shah's $2.0M buy (Nov 6) →

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

CVS insider transactions (Form 4)

Open-market purchases and sales. 43 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 6SEC Prem S. ShahPresidentFirst buy Buy 23,85588,516 held (+37%) $83.89 $2.0M -4.6% —
May 21SEC Larry RobbinsDirector Sell 1,983,3876,213,412 held (−24%) $94.45 $187M -15.3% 83
May 21SEC Larry RobbinsDirector Sell 797,6285,415,633 held (−13%) $93.48 $74.6M -14.4% 83
May 21SEC Larry RobbinsDirector Sell 370,4624,824,799 held (−7%) $93.45 $34.6M -14.4% 83
May 21SEC Larry RobbinsDirector Sell 152,6915,262,942 held (−3%) $94.81 $14.5M -15.6% 83
May 21SEC Larry RobbinsDirector Sell 66,8815,196,061 held (−1%) $95.67 $6.4M -16.4% 83
May 21SEC Larry RobbinsDirector Sell 8005,195,261 held (−0%) $96.28 $77K -16.9% 83
May 21SEC Larry RobbinsDirector Sell 1516,213,261 held (−0%) $95.18 $14K -15.9% 83
May 11SEC Tilak MandadiEvp, Chief Exp & Tech Officer Sell 69,55110,133 held (−87%) $89.58 $6.2M -10.7% —
Jan 27SEC Steven H. NelsonPresidentFirst buyNew positionBefore earnings Buy 24new position $53.70 $1K +49.0% —
Oct 14SEC Heidi B. CapozziEvp And Chief People OfficerFirst buyStake +70% Buy 3585 held (+70%) $56.85 $2K +40.8% —
Oct 14SEC Heidi B. CapozziEvp And Chief People OfficerFirst buyStake +700% Buy 3540 held (+700%) $56.47 $2K +41.7% —
Oct 14SEC Heidi B. CapozziEvp And Chief People OfficerFirst buy Buy 1050 held (+25%) $62.24 $622 +28.6% —

Play with CVS in the Research Lab

Pre-set to CVS's latest insider buy of $10K or more (Nov 6, 2026: Prem S. Shah, $2.0M). Tap to change anything.

All tools →

Share price and insider trades

CVS closeInsider buyInsider sale
6080100120DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-10EEarnings release filed 2026-05-06EEarnings release filed 2026-08-05EEarnings release filed 2026-11-04Bought $2,001,315 on 2026-11-06 · Prem S. ShahSold $6,230,379 on 2026-05-08 · Tilak MandadiSold $34,619,007 on 2026-05-21 · Larry RobbinsSold $95,510,822 on 2026-05-20 · Larry RobbinsSold $187,341,308 on 2026-05-19 · Larry Robbins
Bought, 12 months$2.0M
Sold, 12 months$324M
Insiders buying1
Insiders selling2

CVS Health insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $2.0M and 2 sold $324M of CVS stock on the open market; P/E 10.3 vs. a sector median of 25.0.

Setup Odds: how past setups like this did

CVS's latest insider buying (Nov 6, 2026) matched against every similar buy since 2020.

How it works →

1 insider buying no CEO or CFO $1M+ stock down 0–20% in 3 months

67 of 144 past setups like this beat the S&P 500 over the next 90 days (47%), against 46% for all insider buys.

47 of 100 similar setups beat the S&P 500beat didn't
−40%−20%0% = S&P+20%+40%
How those 144 cases did vs. the S&P 500 over 90 days. Hover a bar for counts.
Outcome Cloud each dot is one of these 144 past setups; the white ring is CVS's buy, result due in 90 days
Beat the S&P 500 ↑Lagged ↓-50%-25%+0%+25%+50%2020202120222023202420252026CORT 2021-06-15: -5% vs S&P +6%BWIN 2026-03-04: -12% vs S&P +11%BHVN 2024-07-19: +44% vs S&P +6%CABO 2022-09-07: -34% vs S&P -1%APPF 2021-10-22: -18% vs S&P -1%AUPH 2026-03-03: +8% vs S&P +12%ADBE 2026-06-26: +18% vs S&P +6%AB 2025-04-04: +16% vs S&P +24%CLVT 2024-08-12: -17% vs S&P +13%CHI 2024-09-11: +8% vs S&P +9%BX 2022-12-05: +12% vs S&P +2%AZO 2023-06-14: +5% vs S&P +2%AXON 2023-06-26: +3% vs S&P +0%CORZ 2025-05-29: +33% vs S&P +10%BKKT 2026-05-18: -12% vs S&P +5%CCNE 2021-06-15: +2% vs S&P +6%ALTG 2022-04-29: -2% vs S&P -1%CB 2025-06-10: -3% vs S&P +8%CLRO 2026-03-06: -27% vs S&P +13%ANNX 2026-05-29: -3% vs S&P +2%BPRN 2024-02-15: -8% vs S&P +6%BCIC 2022-03-28: +0% vs S&P -14%BSM 2026-06-02: +12% vs S&P +1%JKHY 2020-12-22: -3% vs S&P +7%ALGN 2024-08-19: -7% vs S&P +5%CNA 2022-09-20: +5% vs S&P -1%BEN 2025-11-21: +27% vs S&P +4%BBY 2021-12-03: +5% vs S&P -4%APH 2026-02-06: +0% vs S&P +6%IT 2025-12-12: -31% vs S&P -2%CCD 2022-05-26: +9% vs S&P +2%CGEM 2025-10-30: +57% vs S&P +3%AMR 2026-03-20: -4% vs S&P +15%ALV 2022-08-31: +13% vs S&P +0%BH 2021-12-20: +5% vs S&P -2%ALLE 2025-02-21: +12% vs S&P -3%CNA 2023-05-03: -0% vs S&P +12%SAFT 2023-07-21: +7% vs S&P -5%ASH 2022-09-06: +14% vs S&P +3%BNTC 2021-12-09: -27% vs S&P -8%BCAT 2021-03-25: +8% vs S&P +9%AMR 2026-06-16: +5% vs S&P +2%BLDR 2026-03-16: -11% vs S&P +11%CVNA 2026-08-04: +6% vs S&P -2%ACOG 2026-03-10: +2% vs S&P +9%FTK 2023-03-02: -45% vs S&P +5%CNS 2025-11-05: -9% vs S&P +2%AVO 2026-03-18: -7% vs S&P +14%BKKT 2026-06-11: -1% vs S&P +4%ANAB 2021-03-10: +26% vs S&P +9%ASA 2025-01-17: +41% vs S&P -12%COTY 2022-11-16: +49% vs S&P +5%APPN 2020-04-02: +51% vs S&P +24%BHVN 2023-03-22: +84% vs S&P +12%COP 2023-02-23: -0% vs S&P +3%APH 2023-11-09: +23% vs S&P +15%CCIF 2023-08-30: -1% vs S&P +1%CHY 2022-05-26: +11% vs S&P +2%ALGN 2023-05-31: +30% vs S&P +8%FF 2022-06-13: -7% vs S&P +9%AVTR 2025-12-09: -23% vs S&P -0%AUPH 2025-03-04: -1% vs S&P +3%BATRA 2025-11-21: +10% vs S&P +4%CNTM 2024-12-23: -43% vs S&P -5%BNR 2026-04-02: -45% vs S&P +14%CHI 2022-05-26: +8% vs S&P +2%AESI 2024-07-03: +10% vs S&P +3%CPSS 2022-06-29: -13% vs S&P -4%ACR 2023-05-26: +3% vs S&P +4%ACHR 2024-07-03: -29% vs S&P +3%CNA 2022-09-15: +9% vs S&P +3%AMR 2024-03-19: -8% vs S&P +6%APPF 2025-02-18: +1% vs S&P -2%DBI 2021-10-04: -1% vs S&P +11%ATLC 2022-12-09: +7% vs S&P +0%PAM 2026-06-29: -5% vs S&P +4%BLND 2025-12-03: -45% vs S&P -0%CME 2022-11-08: +4% vs S&P +8%BH 2021-11-24: -22% vs S&P -8%APPN 2022-06-03: -10% vs S&P -3%BEN 2024-06-24: -9% vs S&P +5%BCDA 2022-12-20: +12% vs S&P +4%BHC 2025-11-28: -5% vs S&P +1%GBLI 2022-12-16: +20% vs S&P +3%PAM 2026-05-08: +5% vs S&P +4%ACET 2026-04-13: +39% vs S&P +10%CAG 2022-07-26: +4% vs S&P -3%ARMP 2020-03-31: +31% vs S&P +19%AON 2024-05-07: +13% vs S&P +0%ARMP 2022-04-01: -24% vs S&P -16%CSQ 2022-05-26: +8% vs S&P +2%CLIR 2022-07-13: -34% vs S&P -5%CABO 2022-06-03: -10% vs S&P -3%BMN 2023-07-05: -8% vs S&P -5%CLIR 2024-06-26: +1% vs S&P +5%BHC 2025-06-17: +25% vs S&P +11%ANNX 2023-02-14: +3% vs S&P +0%AON 2022-05-09: +5% vs S&P +4%CPNG 2021-12-02: -3% vs S&P -4%CWEN 2020-04-01: +30% vs S&P +26%ALTG 2022-03-28: -22% vs S&P -14%UTI 2025-12-05: +38% vs S&P -0%CHTR 2022-02-02: -29% vs S&P -9%BSX 2021-11-16: +3% vs S&P -6%CIM 2024-12-12: -8% vs S&P -7%CWH 2022-06-13: +19% vs S&P +9%LYV 2022-12-01: -2% vs S&P -3%DBI 2025-01-14: -48% vs S&P -7%CNK 2025-12-22: +18% vs S&P -5%BEN 2025-03-05: +8% vs S&P +3%BATRA 2025-11-10: +2% vs S&P +2%ATXG 2026-08-19: -33% vs S&P -5%APAM 2021-12-15: -17% vs S&P -9%ASAN 2025-08-25: -14% vs S&P +3%CCIF 2023-09-14: -4% vs S&P +5%BEN 2024-09-13: +13% vs S&P +8%CRMT 2024-06-21: -27% vs S&P +5%BLK 2022-04-18: -11% vs S&P -12%AON 2024-02-09: -8% vs S&P +4%AMR 2026-05-15: -13% vs S&P +6%APPN 2022-04-11: -1% vs S&P -11%ADC 2024-12-26: +8% vs S&P -5%AVO 2025-11-14: +12% vs S&P +2%ANAB 2021-05-04: +0% vs S&P +6%FIGS 2022-04-05: -58% vs S&P -15%DASH 2025-11-28: -9% vs S&P +1%AON 2020-05-15: +2% vs S&P +18%BRK-A 2022-10-03: +13% vs S&P +5%COGT 2023-06-13: -5% vs S&P +3%OSG 2020-07-24: -0% vs S&P +8%LMNR 2021-03-25: +11% vs S&P +9%AII 2026-06-11: +54% vs S&P +4%AON 2026-02-12: -1% vs S&P +9%ACHR 2024-08-09: -4% vs S&P +12%CRK 2024-03-25: +26% vs S&P +5%CADL 2024-12-18: +35% vs S&P -4%FBK 2022-10-25: -8% vs S&P +5%BHM 2023-02-16: -19% vs S&P +2%LMNR 2022-03-17: +1% vs S&P -14%SAFT 2023-06-06: -7% vs S&P +6%TDG 2022-06-03: +1% vs S&P -3%CACC 2024-09-20: +2% vs S&P +3%BBD 2026-07-02: +4% vs S&P +3%CCI 2020-10-28: +5% vs S&P +18%This buy: result due Feb 4, 2027
Median vs. S&P 500-1.5%
Average vs. S&P 500-1.6%
Best+84.1%
Worst-58.4%

History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

CVS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2025: $1K bought (1 trades)$1KQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026: $324M sold (8 trades)Q2 2026Q3 2026Q4 2026: $2.0M bought (1 trades)$2.0MQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$2.0M1—0
Q3 2026—0—0
Q2 2026—0$324M8
Q1 2026—0—0
Q4 2025—0—0
Q3 2025—0—0
Q2 2025—0—0
Q1 2025$1K1—0
P/E (trailing)10.3Sector median 25.0
Market value$113.16BHealthcare Plans
Profit margin2.6%Revenue growth +5.4%
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit−$90KOn all tracked purchases -4.5%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 CVS Health insider reported open-market purchases totaling $2.0M, while 2 insiders reported sales totaling $324M. Among insiders with enough purchase history to measure, Larry Robbins (Director) has the highest Insider Score at 83. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CVS earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 4, 2026 -0.7% None -11.0%S&P -2.8% pending
Aug 5, 2026 -2.4% None -7.9%S&P -0.4% +0.5%
May 6, 2026 +6.3% None +8.3%S&P +1.1% +9.8%
Feb 10, 2026 -8.7% None +1.6%S&P -0.3% -1.2%
Oct 29, 2025 +5.7% None -6.7%S&P -1.1% +4.8%
Jul 31, 2025 -1.5% None +0.3%S&P -2.0% +17.1%
May 1, 2025 -2.2% None +1.1%S&P +2.2% -5.1%
Feb 12, 2025 -2.1% None +20.7%S&P +0.7% -1.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

CVS short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 20% of volume sold short2026-08-27: 21% of volume sold short2026-08-28: 33% of volume sold short2026-08-31: 36% of volume sold short2026-09-01: 48% of volume sold short2026-09-02: 47% of volume sold short2026-09-03: 42% of volume sold short2026-09-04: 42% of volume sold short2026-09-08: 34% of volume sold short2026-09-09: 33% of volume sold short2026-09-10: 26% of volume sold short2026-09-11: 35% of volume sold short2026-09-14: 28% of volume sold short2026-09-15: 32% of volume sold short2026-09-16: 31% of volume sold short2026-09-17: 40% of volume sold short2026-09-18: 56% of volume sold short2026-09-21: 39% of volume sold short2026-09-22: 49% of volume sold short2026-09-23: 22% of volume sold short2026-09-24: 26% of volume sold short2026-09-25: 23% of volume sold short2026-09-28: 51% of volume sold short2026-09-29: 36% of volume sold short2026-09-30: 38% of volume sold short2026-10-01: 40% of volume sold short2026-10-02: 19% of volume sold short2026-10-05: 12% of volume sold short2026-10-06: 23% of volume sold short2026-10-07: 22% of volume sold short2026-10-08: 22% of volume sold short2026-10-09: 23% of volume sold short2026-10-12: 22% of volume sold short2026-10-13: 41% of volume sold short2026-10-14: 27% of volume sold short2026-10-15: 22% of volume sold short2026-10-16: 35% of volume sold short2026-10-19: 30% of volume sold short2026-10-20: 59% of volume sold short2026-10-21: 54% of volume sold short2026-10-22: 46% of volume sold short2026-10-23: 48% of volume sold short2026-10-26: 44% of volume sold short2026-10-27: 39% of volume sold short2026-10-28: 23% of volume sold short2026-10-29: 10% of volume sold short2026-10-30: 21% of volume sold short2026-11-02: 15% of volume sold short2026-11-03: 17% of volume sold short2026-11-04: 28% of volume sold short2026-11-05: 13% of volume sold short2026-11-06: 17% of volume sold short2026-11-09: 24% of volume sold short2026-11-10: 41% of volume sold short2026-11-11: 45% of volume sold short2026-11-12: 47% of volume sold short2026-11-13: 32% of volume sold short2026-11-16: 26% of volume sold short2026-11-17: 22% of volume sold short2026-11-18: 28% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 28%20-day average: 26%Prior 2 months: 32%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded CVS

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Sold $1,001 - $15,000 Aug 26, 2024Aug 5, 2026 +47.1%
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +15.9%
John BoozmanSenate Bought $1,001 - $15,000 Jan 29, 2026Feb 15, 2026 +9.1%

CVS stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after CVS insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 6, 2026Prem S. ShahPresident$2.0M +6.6%+4.0% vs S&Ppendingpending

Insiders at CVS Health

InsiderBoughtSoldLast filingPast buys beat S&PScore
Larry RobbinsDirector — $317M May 21, 2026 2 of 4 83
Tilak MandadiEvp, Chief Exp & Tech Officer — $6.2M May 11, 2026 — —
Prem S. ShahPresident $2.0M — Nov 6, 2026 — —
Heidi B. CapozziEvp And Chief People Officer $5K — Apr 2, 2026 — —
Steven H. NelsonPresident $1K — Apr 2, 2026 — —
James David ClarkSvp, Cont & Chief Acct Officer — — Jun 29, 2026 — —
Amy Compton-PhillipsEvp, Chief Medical Officer — — Jun 1, 2026 — —
Brian NewmanCFO — — Jun 1, 2026 — —
Fernando AguirreDirector — — May 22, 2026 — —
Jeffrey R. BalserDirector — — May 15, 2026 — —
C. David Brown IIDirector — — May 15, 2026 — —
Guy P. SansoneDirector — — May 15, 2026 1 of 1 —
Leslie V. NorwalkDirector — — May 15, 2026 — —
J. Scott KirbyDirector — — May 15, 2026 — —
J. David JoynerCEO, President — — Apr 2, 2026 — —
Samrat S. KhichiGeneral Counsel — — Apr 2, 2026 — —
John E. GallinaDirector — — Mar 20, 2026 — —
Roger N. FarahDirector — — Dec 2, 2025 — —
Douglas H. ShulmanDirector — — Nov 21, 2025 — —
Anne A. FinucaneDirector — — Nov 21, 2025 — —

Board links: companies that share insiders with CVS

Directors and executives who filed Form 4s for CVS and another company in the last 12 months.

See the map →
  • BFLYButterfly Network Larry Robbins Director here · Director at BFLY · latest filing Aug 17, 2026
  • CLColgate-Palmolive Brian Newman CFO here · Director at CL · latest filing Oct 2, 2026
  • GMEDGlobus Medical Leslie V. Norwalk Director here · Director at GMED · latest filing May 15, 2026
  • NBIXNeurocrine Biosciences Leslie V. Norwalk Director here · Director at NBIX · latest filing Jul 30, 2026
  • OMFOneMain Holdings Douglas H. Shulman Director here · CEO, President at OMF · latest filing Jan 2, 2026
  • PGRProgressive Roger N. Farah Director here · Director at PGR · latest filing May 12, 2026
  • SYFSynchrony Financial Fernando Aguirre Director here · Director at SYF · latest filing Nov 18, 2026
  • UALUnited Airlines J. Scott Kirby Director here · CEO at UAL · latest filing Nov 10, 2026
  • WSMWilliams-Sonoma Anne A. Finucane Director here · Director at WSM · latest filing Oct 16, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

CVS stock: common questions

Are CVS Health insiders buying CVS stock?

In the past 12 months, 1 insider reported open-market purchases of CVS worth $2.0M. The latest was President Prem S Shah bought $2.0M of CVS at $83.89 — first open-market purchase in our records; raises the stake by 37%.

Are CVS Health insiders selling CVS stock?

2 insiders reported sales worth $324M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CVS's P/E ratio?

CVS trades at about 10.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is CVS's 52-week range?

Over the past year CVS has traded between $69.04 and $109.92. It last closed at $80.02 on Nov 19, 2026.